$325K NIH Phase I Grant: Advancing Urinary Catheter Technology with AvantGuard
AvantGuard has been awarded a $325K NIH Phase I Grant for non-coating antimicrobial, anti-host deposition, anti-inflammatory urinary...
top of page
AvantGuard News
Search
May 11, 2023
AvantGuard Secures $2.85 Million in Oversubscribed Seed Round Funding to Accelerate Research and Dev
NEW YORK, May 11, 2023 /PRNewswire/ -- AvantGuard, a fast-growing company in the antimicrobial industry, announced today the successful...
Apr 18, 2023
AvantGuard Receives $1.7M NIH Grant for AvantGuard247™
AvantGuard, Inc. is pleased to announce a $1.7 million Phase II SBIR award from the National Institutes of Health (NIH) to continue...
Mar 27, 2023
AvantGuard Unveils New Brand Identity Focusing On Innovative Technologies For a Safer World
ITHACA, N.Y., March 23, 2023 /PRNewswire/ -- AvantGuard, announced today the unveiling of its new brand identity as a transformative...
Sep 30, 2021
Halomine Inc. To Receive Funding and R&D Support from The Cornell Center for Material Research
(Ithaca, NY) — Halomine™, Inc., a pioneer in advanced technology for managing surfaces and providing long term protection against...
Jun 30, 2021
Diversey and Halomine Announce a Strategic Alliance to Drive the Halofilm™ Technology Globally
FORT MILL, S.C., June 29, 2021 (GLOBE NEWSWIRE) - Diversey Holdings, Ltd. (NASDAQ: DSEY), a leading provider of hygiene, infection...
Jun 23, 2020
Halomine™ Receives“Red Bear Angel” Funding
$77k Investment for Rollout of HaloFilm™ (Ithaca, NY) — Halomine™, a start-up company developing a suite of novel, long-acting,...
Jun 9, 2020
National Science Foundation Awards Halomine™ 2nd Major Grant
$256K Award to Study Efficacy Against Coronavirus, Other Viruses (Ithaca, NY) — Halomine™, Inc., developer of a suite of novel,...
May 26, 2020
National Science Foundation Awards Halomine™ Major Grant
$225K Award Recognizes “Excellent Efficacy Against Pathogens” (Ithaca, NY) — Halomine™, Inc. today announced that it has received a...
bottom of page